PDA

View Full Version : FDA approves Ibrance for postmenopausal women with advanced breast cancer

News
02-05-2015, 04:14 AM
The U.S. Food and Drug Administration has granted accelerated approval to Ibrance (palbociclib) to treat advanced (metastatic) breast cancer.

More... (http://www.medicalnewstoday.com/releases/288987.php)